Clinical Trial Update: Immune Responses With Reduxium [NA]

View source ↗

Summary

Completed clinical trial update reporting immune responses for Reduxium, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Tolerance
• Viral Infection

Drugs mentioned

• Reduxium

Snippet

Sponsor: Ogevity Therapeutics, Inc. | Conditions: Immune Tolerance, Viral Infection | NA | Status: COMPLETED | Results posted: 2022-05-27